Chemical subgroup
J05AJ – Integrase-Inhibitoren
5Decisions
11Patient groups
Added benefit by patient group
- Considerable1
- Minor1
- Not proven9
Decisions, newest first
- 2025-08-07VocabriaCabotegravirNot proven
- 2021-10-21VocabriaCabotegravirNot proven
- 2021-07-15TivicayDolutegravirNot proven: 2 of 2 patient groups
- 2017-09-21TivicayDolutegravirNot proven: 2 of 2 patient groups
- 2014-08-07TivicayDolutegravirConsiderable: 1 of 5 patient groupsMinor: 1 of 5 patient groupsNot proven: 3 of 5 patient groups
Data status: 2026-10-29